(Q33897433)

29 July 2017

title

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial (English)

1 reference

29 July 2017

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

randomized experiment

1 reference

1 reference

1

Nancy A Rigotti

1 reference

29 July 2017

2

Andrew L Pipe

1 reference

29 July 2017

Neal L Benowitz

3

1 reference

29 July 2017

Carmen Arteaga

series ordinal

4

1 reference

29 July 2017

Dahlia Garza

series ordinal

5

1 reference

29 July 2017

Serena Tonstad

series ordinal

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

4 January 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

121

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

221-229

1 reference

Varenicline for tobacco dependence

29 July 2017

uses

randomized experiment

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Nicotine receptor partial agonists for smoking cessation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 4. Efficacy of risk factor management.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4096941

Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20048210

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20048210

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1161/CIRCULATIONAHA.109.869008

1 reference

29 July 2017

1 reference

29 July 2017

1 reference